02.08.2023
Therapeutics
$1,929,856.00
30 months
Targeting the mycobiome in patients with Crohn's Disease
This grant aims, through conducting two clinical trials, to position anti-fungal medications as a therapeutic option for patients harboring damaging fungal strains.